Clinically Relevant Benefits Seen for GLP-1RA, SGLTi Treatment of T1DM
THURSDAY, March 2, 2023 (HealthDay News) — Glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is) are beneficial for treating type 1 diabetes mellitus (T1DM), with similar reductions in glycated h…
Learn MoreTargeted Therapies Seem Beneficial for Immune Checkpoint Inhibitor-Related Myotoxicity
THURSDAY, March 2, 2023 (HealthDay News) — A strategy including identification of severe immune checkpoint inhibitor (ICI)-related myocarditis based on screening combined with active ventilation and treatment seems beneficial for reducing the myotoxi…
Learn MoreGenetic Diseases Associated With 41 Percent of Infant Deaths
THURSDAY, March 2, 2023 (HealthDay News) — Single-locus genetic diseases are the most common cause of infant mortality and are associated with 41 percent of deaths, according to a study published online Feb. 9 in JAMA Network Open.Mallory J. Owen, M….
Learn MoreEmbolization Treatment Could Offer Drug-Free Relief From Enlarged Prostate
THURSDAY, March 2, 2023 (HealthDay News) — Men suffering from an enlarged prostate can receive long-term relief from a minimally invasive procedure that partially blocks blood flow to the gland, new research reports.The procedure, called prostate ar…
Learn MoreAspirin Discontinuation Noninferior for Preventing Preeclampsia
THURSDAY, March 2, 2023 (HealthDay News) — For pregnant individuals at high risk for preeclampsia with a normal soluble fms-like tyrosine kinase-1 to placental growth factor (sFlt-1:PlGF) ratio, aspirin discontinuation between 24 and 28 weeks of gest…
Learn MoreAcute Care Use Increased for Cancer Patients With Higher Symptom Complexity
THURSDAY, March 2, 2023 (HealthDay News) — For patients with cancer, those with higher symptom complexity scores are more likely to use acute care, according to a study published in the February issue of the Journal of the National Comprehensive Canc…
Learn MoreIs an Allergy to a COVID Vaccine Always Real? Placebo Trial Casts Doubt
THURSDAY, March 2, 2023 (HealthDay) — Allergic reactions to the Pfizer or Moderna COVID vaccines are very rare, and a new study questions whether many of those that do occur are even real.In a small new study of 16 people who said they’d experienced …
Learn MoreRacism Brings Worse Heart Health for Black Women
THURSDAY, March 2, 2023 (HealthDay News) — Black women who are exposed to certain forms of racism may be more likely to develop heart disease, researchers say.Specifically, Black women who said they faced discrimination in employment, housing and in…
Learn MoreCancer Screenings Rise in States With Mandatory Paid Sick Leave
THURSDAY, March 2, 2023 (HealthDay News) — Many Americans are not getting recommended cancer screenings, and a new study hints at one way to push the needle: paid sick leave from work.Researchers found that in areas of the United States that passed m…
Learn MoreOlder Black Men Face Higher Risk of Death After Surgery
THURSDAY, March 2, 2023 (HealthDay News) — Older Black men are more likely than others to die after surgery, according to a new study. Black men have a higher chance of dying within 30 days of surgery compared to Black women and white adults, and the…
Learn More